Fluorouracil (5‑FU) – Patient Information (Australia)

Fluorouracil (often shortened to 5‑FU) is a widely used medicine in oncology. It belongs to a group of medicines called antimetabolites. Fluorouracil works by interfering with how rapidly dividing cells make and use DNA and RNA, which helps slow or stop the growth of certain cancers.

This page is designed to be patient-friendly and practical. It explains what Fluorouracil is, how it works, how it behaves in the body, typical uses, timing considerations, and important safety information.

Basic product information

• Medicine name: Fluorouracil (5‑fluorouracil; 5‑FU)
• Type: Antimetabolite (cytotoxic chemotherapy)
• Common forms: Usually available as an injectable medicine (for intravenous or other clinical delivery pathways).
• Also known as: 5‑FU
• Manufacturer/brand names: Different brands may exist. Your pharmacy will provide the exact product supplied.

In Australia, cancer medicines may be supplied through hospitals, specialist clinics, or authorised dispensing arrangements. Availability can vary by brand and formulation.

How Fluorouracil works (mechanism of action)

Fluorouracil is converted inside the body into active metabolites that interfere with normal nucleic acid function. In simple terms, it limits the materials and steps cancer cells need to grow and divide.

Key mechanisms include:

• Inhibiting thymidylate synthase: This enzyme helps cells produce thymidine, a building block for DNA. When thymidylate synthase is blocked, DNA synthesis is impaired.
• Incorporating into RNA: Some 5‑FU metabolites can disrupt RNA processing, affecting protein production.
• Cell-cycle effects: Rapidly dividing cells (such as many cancer cells) are particularly affected, which is why the medicine is used in oncology.

Fluorouracil does not selectively target cancer cells only; it also affects some normal rapidly dividing tissues (for example, bone marrow and parts of the gastrointestinal tract). This is a major reason side effects can occur.

Pharmacokinetics (what the body does to the medicine)

Pharmacokinetics describes how a medicine moves through the body—how it is absorbed (if relevant), distributed, metabolised, and eliminated.

Important notes for patients: Fluorouracil is typically administered in a way that bypasses the digestive system (e.g., by injection), so “absorption” is not the same topic as for tablets taken by mouth.

• Distribution: After administration, 5‑FU distributes through body fluids and tissues. It can cross into tissues affected by cancer.
• Metabolism: The liver and other tissues metabolise 5‑FU. A key route involves the enzyme dihydropyrimidine dehydrogenase (DPD), which helps break down 5‑FU. Reduced DPD activity can increase the risk of severe toxicity.
• Elimination: Metabolites are eliminated mainly via the kidneys (through urine).
• Half-life: The exact half-life can vary by schedule and patient factors. Clinical dosing regimens are designed to maintain effective drug exposure while managing toxicity.

Because metabolism and clearance vary among individuals, clinicians may consider relevant factors such as liver function, kidney function, and DPD status (where appropriate) when planning treatment.

Typical use: what Fluorouracil is used for

Fluorouracil is used to treat certain cancers. The exact indication depends on your diagnosis and the treatment plan set by your oncology team. Common uses include:

• Colorectal cancer: Often used in combination regimens.
• Gastric (stomach) and gastrointestinal cancers: Used in selected combination therapies.
• Other solid tumours: In certain protocols and combinations where 5‑FU is part of standard treatment.

The medicine may also be used in different schedules (continuous infusion or intermittent dosing) depending on the protocol. Combination therapy is common.

Indications and clinical situations

“Indication” means the condition the medicine is used to treat. For Fluorouracil, indications generally relate to certain cancers, often as part of multi-drug therapy. Examples include:

• Adjuvant (after surgery) therapy: To reduce the risk of cancer recurrence.
• Neoadjuvant (before surgery) therapy: To shrink tumours prior to surgery in selected cases.
• Metastatic or advanced disease: To control tumour growth and symptoms, and to prolong survival where appropriate.

Your treatment protocol (including drug combinations and schedule) is tailored to the cancer type, stage, previous treatments, and your general health.

Dosing and timing (general guidance for patients)

Dosing of Fluorouracil is individualised based on protocol and patient factors. Your oncology team will calculate your dose, often using:

• Body surface area (BSA) (commonly used for many chemotherapy dosing regimens), or other clinical dosing methods
• Performance status and overall health
• Blood test results (e.g., neutrophils, platelets)
• Organ function (liver and kidney function)
• Previous treatment and side-effect tolerance
• Planned schedule (intermittent dosing vs continuous infusion)

Timing tips you can plan around:

• Follow appointment timing exactly: Chemotherapy schedules are designed carefully; delays may affect effectiveness.
• Blood tests: Often done shortly before each treatment cycle to determine whether dosing can proceed and at what level.
• Monitor symptoms between cycles: Many side effects appear days after treatment.
• Keep a treatment diary: Note dates, symptoms, and any supportive medicines taken.

If you miss an appointment or there is a delay, contact your treating team promptly for instructions.

Food interactions

Fluorouracil is not generally affected by food in the same way as oral medicines, because it is typically delivered by injection. However, maintaining good nutrition is still important.

During chemotherapy you may experience nausea, appetite changes, diarrhoea, or mouth sores. The focus should be on:

• Staying hydrated (unless your doctor has restricted fluids)
• Eating small, frequent meals if appetite is low
• Avoiding foods that worsen symptoms such as very spicy or high-fat meals if they trigger nausea or diarrhoea
• Managing mouth soreness with soft, bland foods if needed

If you have specific dietary needs (for example, diabetic diet plans, swallowing difficulties, or kidney restrictions), ask your care team or a dietitian for tailored advice.

Alcohol interactions

Alcohol can worsen some chemotherapy-related side effects (such as nausea, fatigue, dehydration, and sleep disturbances) and may also affect liver metabolism. Because of this, it’s usually recommended to avoid alcohol or keep it to a minimum during treatment—unless your oncology team advises otherwise.

• Risk of dehydration: Alcohol may increase dehydration, especially if you have vomiting or diarrhoea.
• GI irritation: Alcohol can aggravate mouth irritation or stomach upset.
• Medication sensitivity: Fatigue and dizziness may be more pronounced.

If you are unsure whether you can drink alcohol for social reasons, discuss it with your treating clinician.

Interactions with other medicines

Drug interactions can affect 5‑FU levels or increase the risk of toxicity. Always inform your healthcare team about: all medicines you take, including prescription medicines, over-the-counter products, vitamins, herbal remedies, and supplements.

Examples of interaction concerns (not exhaustive):

• Medicines that affect DPD activity: Reduced DPD function can increase risk of severe toxicity from 5‑FU. Certain medications may also influence metabolism—your clinician will check compatibility.
• Leucovorin (folinic acid) combinations: In colorectal cancer and other regimens, leucovorin is commonly used and can increase 5‑FU effectiveness. This is part of the intended protocol, but it also affects side-effect risk.
• Warfarin and blood thinning medicines: Some chemotherapy regimens can affect bleeding risk and INR control. Your clinician may monitor coagulation more closely.
• Phenytoin: Some drugs can change levels of phenytoin or other medicines; close monitoring may be needed.

If you need a new medication (including antibiotics, anti-nausea medicines, pain relief, or complementary products), ask your oncology team or pharmacist to confirm it is safe with your regimen.

Safety profile: common and serious side effects

Like all chemotherapy medicines, Fluorouracil can cause side effects. Some are common and manageable, while others may be serious and require prompt medical attention.

Common side effects

• Low blood counts: Increased risk of infection (neutropenia), anaemia, or bleeding/bruising (thrombocytopenia)
• Gastrointestinal symptoms: Diarrhoea, nausea, vomiting, abdominal discomfort
• Mouth changes: Mouth sores (stomatitis), mouth pain, taste changes
• Fatigue: Feeling tired or weak
• Skin changes: Rash, dryness, sensitivity
• Hair changes: Hair loss is not always as pronounced as with some other chemotherapy agents, but it can occur depending on regimen
• Tearing/eye irritation: Some patients report irritation around the eyes or increased tearing

Serious side effects – seek urgent medical care

Contact your treating team immediately or seek urgent care if you experience:

• Fever or signs of infection: A fever (often defined as 38°C or higher) or chills, sore throat, or worsening weakness
• Severe diarrhoea: Especially if it is frequent, watery, or accompanied by dehydration
• Severe mouth sores: Unable to drink fluids or significant pain
• Signs of dehydration: Dizziness, reduced urine, dry mouth, or rapid heartbeat
• Allergic-type reactions: Swelling of face/lips, difficulty breathing, or widespread hives
• Uncontrolled bleeding or unusual bruising: Such as nosebleeds or blood in urine/stool
• Neurological symptoms: Severe confusion or unusual severe weakness

Because severity varies widely depending on dose and individual risk factors, always follow your clinic’s “when to call” instructions.

DPD deficiency and increased toxicity risk

The enzyme DPD helps break down fluorouracil. Some people have reduced DPD activity (sometimes due to inherited variation). Reduced DPD activity can significantly increase the risk of severe and potentially life‑threatening toxicity.

• Your clinician may consider DPD testing based on local practice and your situation.
• If you previously experienced unexpectedly severe reactions to 5‑FU, tell your clinician.

Practical use tips (day-to-day support)

The following tips can help many people manage chemotherapy more comfortably. Your oncology team may provide additional, regimen-specific recommendations.

• Hydration strategy: Aim for regular fluid intake if you are allowed to drink normally. If you develop diarrhoea or vomiting, discuss an oral rehydration plan promptly.
• Oral care: Use gentle mouth rinses as recommended by your clinic. Brush with a soft toothbrush and avoid harsh alcohol-containing mouthwashes if they worsen soreness.
• Nutrition: Choose calorie- and protein-rich foods in small servings. A dietitian can help with personalised options.
• Infection prevention: Practice good hand hygiene, avoid close contact with sick people, and report fever immediately.
• Energy management: Plan rest periods and light activity (if safe) to reduce fatigue.
• Track symptoms: Keep notes of diarrhoea frequency, mouth pain, nausea, and any new symptoms. This helps clinicians adjust supportive care quickly.
• Pregnancy and contraception: Fluorouracil can harm a developing baby. Discuss pregnancy prevention and family planning with your oncology team before treatment.

Alternative options

Treatment depends on cancer type, stage, and prior therapies. If Fluorouracil is not suitable, options may include:

• Other chemotherapy agents or combinations (e.g., therapies used in colorectal and other gastrointestinal cancers)
• Targeted therapies (for cancers with specific molecular targets)
• Immunotherapy (where appropriate based on tumour markers)
• Radiation therapy or surgical approaches
• Best supportive care to manage symptoms and improve quality of life

Your oncology team can explain why Fluorouracil is recommended in your specific case and what alternatives are considered if changes are needed due to side effects or treatment goals.

Market and legal context in Australia (overview)

In Australia, chemotherapy medicines are tightly regulated and typically administered through specialist oncology services. Supply, prescribing, and administration practices are governed by national and state/territory regulatory frameworks.

Key practical points for patients in Australia:

• Clinical oversight: Fluorouracil is used under supervision of oncology professionals.
• Monitoring requirements: Treatment often requires regular blood tests and follow-up appointments.
• Supportive medicines: Anti-nausea medicines, mouth care measures, and other supports may be provided alongside chemotherapy.
• Safety handling: Cytotoxic medicines require specific handling procedures in healthcare settings.

If you need information about your local care pathway, your treating team or pharmacist can explain how medicines are arranged and delivered.

Recent guidance and clinical practice considerations

Oncology practice evolves over time as evidence updates. In recent years, increased attention has been given to:

• DPD deficiency risk: Awareness of DPD-related toxicity has grown, and DPD testing may be considered in appropriate settings.
• Managing severe diarrhoea and mucositis: Protocol-based dose adjustments and supportive care are used to reduce complications.
• Treatment individualisation: Dose adjustments based on blood counts, organ function, and prior toxicity are standard practice.

Always rely on the most up-to-date instructions provided by your oncology team, as regimens and supportive care can differ by cancer type and protocol.

Delivery and availability (what to expect)

Availability of Fluorouracil products can vary depending on formulation, hospital supply arrangements, and scheduled chemotherapy delivery systems. Many patients receive their chemotherapy via a healthcare facility rather than taking it at home.

• How you’ll receive it: Typically via a hospital day unit or oncology clinic setting.
• Preparation time: Appointments often include pre-treatment assessment and blood tests.
• Support medicines: Some supportive medicines may be dispensed for use at home (for example, anti-nausea medicines), depending on your regimen.

Your pharmacy or care coordinator can confirm expected delivery arrangements and any steps you need to complete before treatment.

Table: quick reference summary

FAQ

1. Is Fluorouracil a steroid or an antibiotic?

No. Fluorouracil is a chemotherapy (antimetabolite) medicine. It is not a steroid and not an antibiotic.

2. How soon will side effects start?

This depends on the schedule and the person. Some side effects (such as fatigue or nausea) can start within days, while others (like diarrhoea or mouth sores) may appear later. Your clinic can give a timeframe based on your regimen.

3. What should I do if I get a fever?

Fever during chemotherapy can signal a serious infection due to low white blood cell counts. Seek urgent medical advice immediately and follow your clinic’s “fever instructions.”

4. Can I take over-the-counter medicines?

Many over-the-counter medicines may be used, but some can interact or worsen side effects. Ask your pharmacist or oncology team before taking new products—especially anti-diarrhoea medicines, pain relief, cold/flu products, or herbal supplements.

5. Does Fluorouracil interact with food?

Because it is usually given by injection, direct food interactions are not typically the main issue. However, food affects how you feel and your ability to tolerate side effects, so focus on hydration and gentle, nourishing foods.

6. Can I drink alcohol while on treatment?

It’s generally recommended to avoid or minimise alcohol during chemotherapy. Alcohol can worsen dehydration and GI symptoms and may affect metabolism. Confirm with your treating team if you have questions.

7. How is dosing adjusted if side effects occur?

Clinicians may delay next doses or reduce dose levels based on blood counts and the severity of side effects such as diarrhoea or mucositis. Always report symptoms early so the regimen can be adjusted safely.

8. What if I miss a treatment appointment?

Contact your oncology clinic promptly. Chemotherapy regimens are time-sensitive, and staff will advise the safest plan.

9. Are there “alternative” medicines I can switch to?

There may be alternatives, but the best choice depends on your cancer type and treatment goals. Discuss options with your oncology team if you experience intolerable side effects or if treatment adjustments are needed.

10. Where can I find the exact instructions for my regimen?

Your treating team provides a written treatment plan including schedule, supportive medicines, and specific instructions for symptoms, blood tests, and dose adjustments.

Important: This information is general and may not cover every situation. Your oncology team and pharmacist can tailor advice to your individual regimen, blood results, and medical history. If you are unsure about any symptom or medication, contact your healthcare providers promptly.